Ms
Kate
Taylor

Partner & Head of Life Sciences

York Office

Life sciences

Telephone. +44(0) 1904 732 120
Email. [email protected]

Experience

Kate has over 20 years experience in the patent profession. Her expertise lies in life sciences and biopharmaceutical fields, with a particular emphasis on biologic products. In addition to patent drafting and prosecution, Kate advises on all aspects of patent strategy and life cycle management, regularly handling due diligence matters and opinions relating to validity and infringement. She has extensive experience representing clients in opposition and appeal proceedings before the EPO.

Qualifications

Patent Attorney

Chartered (UK)
European
UK


BSC

Genetics

MSC

Industrial Biotechnology

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property

Publications

HGF ranked 'Gold' in the Financial Times special report

View publication online

HGF continue to be highly ranked in The Legal 500 United Kingdom 2020 rankings

View publication online

HGF ranked 'Gold' in the Financial Times special report

View publication online

Conferences: 2020

September 10th 2020

IPBC Connect 2020

Speaker

Event details

Conferences: 2019

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

Related News

Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.